1887

Abstract

Purpose. Neisseria meningitidis is the leading global cause of meningitis and sepsis. Detection, followed by identification, of bacterial pathogens is important in medicine and public health. In the present study, we used the ribosome display technique to select single-chain variable fragments (scFv) that are specific to the surface-exposed fHbp antigen of N. meningitidis.

Methodology. The recombinant fHbp protein was used as the antigen for the immunization of BALB/c mice. Anti-fHbp VH/k chain ribosome display libraries were assembled by joining VH and k into the VH/k chain with a specially constructed linker by PCR overlap extension. The scFv library was panned against the recombinant fHbp protein by using a single round of the ribosome display method via a rabbit reticulocyte lysate system.

Results/Key findings. The selected anti-fHbp antibody exhibited high affinity and specificity in the enzyme-linked immunosorbent assay (ELISA) and the whole bacterial cell enzyme-linked immunosorbent assay (Bact-ELISA).

Conclusion. The affinity of the selected scFv was ~8.65×10 M. The isolated scFv can provide the basis for developing a diagnostic kit.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.000744
2018-05-08
2019-10-14
Loading full text...

Full text loading...

/deliver/fulltext/jmm/67/6/820.html?itemId=/content/journal/jmm/10.1099/jmm.0.000744&mimeType=html&fmt=ahah

References

  1. McNeil LK, Zagursky RJ, Lin SL, Murphy E, Zlotnick GW et al. Role of factor H binding protein in Neisseria meningitidis virulence and its potential as a vaccine candidate to broadly protect against meningococcal disease. Microbiol Mol Biol Rev 2013;77:234–252 [CrossRef][PubMed]
    [Google Scholar]
  2. Rosenstein NE, Perkins BA, Stephens DS, Popovic T, Hughes JM. Meningococcal disease. N Engl J Med 2001;344:1378–1388 [CrossRef][PubMed]
    [Google Scholar]
  3. Kesanopoulos K, Tzanakaki G, Levidiotou S, Blackwell C, Kremastinou J. Evaluation of touch-down real-time PCR based on SYBR Green I fluorescent dye for the detection of Neisseria meningitidis in clinical samples. FEMS Immunol Med Microbiol 2005;43:419–424 [CrossRef][PubMed]
    [Google Scholar]
  4. Kaldor J, Asznowicz R, Buist DG. Latex agglutination in diagnosis of bacterial infections, with special reference to patients with meningitis and septicemia. Am J Clin Pathol 1977;68:284–289 [CrossRef][PubMed]
    [Google Scholar]
  5. Masignani V, Comanducci M, Giuliani MM, Bambini S, Adu-Bobie J et al. Vaccination against Neisseria meningitidis using three variants of the lipoprotein GNA1870. J Exp Med 2003;197:789–799 [CrossRef][PubMed]
    [Google Scholar]
  6. Fletcher LD, Bernfield L, Barniak V, Farley JE, Howell A et al. Vaccine potential of the Neisseria meningitidis 2086 lipoprotein. Infect Immun 2004;72:2088–2100 [CrossRef][PubMed]
    [Google Scholar]
  7. Díaz A, Ferreira A, Sim RB. Complement evasion by Echinococcus granulosus: sequestration of host factor H in the hydatid cyst wall. J Immunol 1997;158:3779–3786[PubMed]
    [Google Scholar]
  8. Madico G, Welsch JA, Lewis LA, McNaughton A, Perlman DH et al. The meningococcal vaccine candidate GNA1870 binds the complement regulatory protein factor H and enhances serum resistance. J Immunol 2006;177:501–510 [CrossRef][PubMed]
    [Google Scholar]
  9. Lambris JD, Ricklin D, Geisbrecht BV. Complement evasion by human pathogens. Nat Rev Microbiol 2008;6:132–142 [CrossRef][PubMed]
    [Google Scholar]
  10. Beernink PT, Granoff DM. The modular architecture of meningococcal factor H-binding protein. Microbiology 2009;155:2873–2883 [CrossRef][PubMed]
    [Google Scholar]
  11. Malito E, Faleri A, Lo Surdo P, Veggi D, Maruggi G et al. Defining a protective epitope on factor H binding protein, a key meningococcal virulence factor and vaccine antigen. Proc Natl Acad Sci USA 2013;110:3304–3309 [CrossRef][PubMed]
    [Google Scholar]
  12. Alibakhshi A, Abarghooi Kahaki F, Ahangarzadeh S, Yaghoobi H, Yarian F et al. Targeted cancer therapy through antibody fragments-decorated nanomedicines. J Control Release 2017;268:323–334 [CrossRef][PubMed]
    [Google Scholar]
  13. Ahmed A, Rushworth JV, Hirst NA, Millner PA. Biosensors for whole-cell bacterial detection. Clin Microbiol Rev 2014;27:631–646 [CrossRef][PubMed]
    [Google Scholar]
  14. Siontorou CG. Nanobodies as novel agents for disease diagnosis and therapy. Int J Nanomedicine 2013;8:4215–4227 [CrossRef][PubMed]
    [Google Scholar]
  15. Holliger P, Hudson PJ. Engineered antibody fragments and the rise of single domains. Nat Biotechnol 2005;23:1126–1136 [CrossRef][PubMed]
    [Google Scholar]
  16. Mattheakis LC, Bhatt RR, Dower WJ. An in vitro polysome display system for identifying ligands from very large peptide libraries. Proc Natl Acad Sci USA 1994;91:9022–9026 [CrossRef][PubMed]
    [Google Scholar]
  17. Binz HK, Amstutz P, Kohl A, Stumpp MT, Briand C et al. High-affinity binders selected from designed ankyrin repeat protein libraries. Nat Biotechnol 2004;22:575–582 [CrossRef][PubMed]
    [Google Scholar]
  18. He M, Taussig MJ. Ribosome display of antibodies: expression, specificity and recovery in a eukaryotic system. J Immunol Methods 2005;297:73–82 [CrossRef][PubMed]
    [Google Scholar]
  19. Weichhart T, Horky M, Söllner J, Gangl S, Henics T et al. Functional selection of vaccine candidate peptides from Staphylococcus aureus whole-genome expression libraries in vitro. Infect Immun 2003;71:4633–4641 [CrossRef][PubMed]
    [Google Scholar]
  20. He M, Taussig MJ. Ribosome display: cell-free protein display technology. Brief Funct Genomic Proteomic 2002;1:204–212 [CrossRef][PubMed]
    [Google Scholar]
  21. Yarian F, Bandehpour M, Seyed N, Kazemi B. Cloning, expression and purification of the factor H binding protein and its interaction with factor H. Iran J Microbiol 2016;8:29–35[PubMed]
    [Google Scholar]
  22. Luo Y, Xia Y. Selection of single-chain variable fragment antibodies against fenitrothion by ribosome display. Anal Biochem 2012;421:130–137 [CrossRef][PubMed]
    [Google Scholar]
  23. Thornton JA. Splicing by overlap extension PCR to obtain hybrid DNA products. Methods Mol Biol 2016;1373:43–49 [CrossRef][PubMed]
    [Google Scholar]
  24. Lee MS, Kwon MH, Kim KH, Shin HJ, Park S et al. Selection of scFvs specific for HBV DNA polymerase using ribosome display. J Immunol Methods 2004;284:147–157 [CrossRef][PubMed]
    [Google Scholar]
  25. Azizi A, Arora A, Markiv A, Lampe DJ, Miller TA et al. Ribosome display of combinatorial antibody libraries derived from mice immunized with heat-killed Xylella fastidiosa and the selection of MopB-specific single-chain antibodies. Appl Environ Microbiol 2012;78:2638–2647 [CrossRef][PubMed]
    [Google Scholar]
  26. Sanger F, Nicklen S, Coulson AR. DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci USA 1977;74:5463–5467 [CrossRef][PubMed]
    [Google Scholar]
  27. Sankian M, Yousefi M, Pazouki N, Varasteh A. One-step purification of histidine-tagged profilin with high purity and yield by using metal precipitation. Biotechnol Appl Biochem 2007;47:185–189 [CrossRef][PubMed]
    [Google Scholar]
  28. Abdillahi H, Poolman JT. Typing of group-B Neisseria meningitidis with monoclonal antibodies in the whole-cell ELISA. J Med Microbiol 1988;26:177–180[PubMed]
    [Google Scholar]
  29. Beatty JD, Beatty BG, Vlahos WG. Measurement of monoclonal antibody affinity by non-competitive enzyme immunoassay. J Immunol Methods 1987;100:173–179 [CrossRef][PubMed]
    [Google Scholar]
  30. Lefranc MP. IMGT, the international ImMunoGeneTics database. Nucleic Acids Res 2003;31:307–310 [CrossRef][PubMed]
    [Google Scholar]
  31. Brochet X, Lefranc MP, Giudicelli V. IMGT/V-QUEST: the highly customized and integrated system for IG and TR standardized V-J and V-D-J sequence analysis. Nucleic Acids Res 2008;36:W503–W508 [CrossRef][PubMed]
    [Google Scholar]
  32. Bandehpour M, Yarian F, Ahangarzadeh S. Bioinformatics evaluation of novel ribosome display-selected single chain variable fragment (scFv) structure with factor H binding protein through docking. J Theor Comput Chem 2017;16:1750021 [CrossRef]
    [Google Scholar]
  33. Köhler G, Milstein C. Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 1975;256:495–497 [CrossRef][PubMed]
    [Google Scholar]
  34. Wang SH, Zhang JB, Zhang ZP, Zhou YF, Yang RF et al. Construction of single chain variable fragment (ScFv) and BiscFv-alkaline phosphatase fusion protein for detection of Bacillus anthracis. Anal Chem 2006;78:997–1004 [CrossRef][PubMed]
    [Google Scholar]
  35. Hanes J, Plückthun A. In vitro selection and evolution of functional proteins by using ribosome display. Proc Natl Acad Sci USA 1997;94:4937–4942 [CrossRef][PubMed]
    [Google Scholar]
  36. Wang SH, Du XY, Huang YM, Lin DS, Hart PL et al. Detection of deoxynivalenol based on a single-chain fragment variable of the antideoxynivalenol antibody. FEMS Microbiol Lett 2007;272:214–219 [CrossRef][PubMed]
    [Google Scholar]
  37. Cattepoel S, Hanenberg M, Kulic L, Nitsch RM. Chronic intranasal treatment with an anti-Aβ(30-42) scFv antibody ameliorates amyloid pathology in a transgenic mouse model of Alzheimer's disease. PLoS One 2011;6:e18296 [CrossRef][PubMed]
    [Google Scholar]
  38. Coia G, Hudson PJ, Irving RA. Protein affinity maturation in vivo using E. coli mutator cells. J Immunol Methods 2001;251:187–193 [CrossRef][PubMed]
    [Google Scholar]
  39. Krag DN, Shukla GS, Shen GP, Pero S, Ashikaga T et al. Selection of tumor-binding ligands in cancer patients with phage display libraries. Cancer Res 2006;66:7724–7733 [CrossRef][PubMed]
    [Google Scholar]
  40. Eisenhardt SU, Schwarz M, Schallner N, Soosairajah J, Bassler N et al. Generation of activation-specific human anti-alphaMbeta2 single-chain antibodies as potential diagnostic tools and therapeutic agents. Blood 2007;109:3521–3528 [CrossRef][PubMed]
    [Google Scholar]
  41. Andris-Widhopf J, Steinberger P, Fuller R, Rader C, Barbas CF. Generation of human Fab antibody libraries: PCR amplification and assembly of light- and heavy-chain coding sequences. Cold Spring Harb Protoc 2011;2011:pdb.prot065565 [CrossRef][PubMed]
    [Google Scholar]
  42. He M, Taussig MJ. Antibody-ribosome-mRNA (ARM) complexes as efficient selection particles for in vitro display and evolution of antibody combining sites. Nucleic Acids Res 1997;25:5132–5134 [CrossRef][PubMed]
    [Google Scholar]
  43. Hanes J, Jermutus L, Weber-Bornhauser S, Bosshard HR, Plückthun A. Ribosome display efficiently selects and evolves high-affinity antibodies in vitro from immune libraries. Proc Natl Acad Sci USA 1998;95:14130–14135 [CrossRef][PubMed]
    [Google Scholar]
  44. Ahangarzadeh S, Bandehpour M, Kazemi B. Selection of single-chain variable fragments specific for Mycobacterium tuberculosis ESAT-6 antigen using ribosome display. Iran J Basic Med Sci 2017;20:327–333 [CrossRef][PubMed]
    [Google Scholar]
  45. Zhou L, Mao WP, Fen J, Liu HY, Wei CJ et al. Selection of scFvs specific for the HepG2 cell line using ribosome display. J Biosci 2009;34:221–226 [CrossRef][PubMed]
    [Google Scholar]
  46. Yuan Q, Xia Y, Nian S, Yin Y, Cao Y et al. Selection of single chain fragments against the phytopathogen Xanthomonas axonopodis pv. citri by ribosome display. Enzyme Microb Technol 2007;41:383–389 [CrossRef]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.000744
Loading
/content/journal/jmm/10.1099/jmm.0.000744
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error